Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first‐line setting by R. Gencheva, M. Petrova, P. Kraleva, S. Hadjidekova, M. Radanova, N. Conev, D. Stoyanov, J. Arabadjiev, E. Tazimova, S. Bachurska, M. Eneva, M. Tsvetkova, G. Zhbantov, T. Karanikolova, D. Manov, A. Ivanova, M. Taushanova‐Hadjieva, R. Staneva, E. Dimitrova, I. Donev

Get full text